BACKGROUND: Low-grade inflammation is associated with depression, but studies of specific symptoms are relatively scarce. Association between inflammatory markers and specific symptoms may provide insights into potential mechanism of inflammation-related depression. Using longitudinal data, we have tested whether childhood serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels are associated with specific depressive symptoms in early adulthood. METHODS: In the ALSPAC birth cohort, serum IL-6 and CRP levels were assessed at age 9 years and 19 depressive symptoms were assessed at age 18 years. We used modified Poisson generalised linear regression with robust error variance to estimate the risk ratio (RR) and 95% confidence interval (95% CI) for each depressive symptom. In addition, we used confirmatory factor analysis to create two continuous latent variables representing somatic/neurovegetative and psychological dimension scores. Structural equation modelling was used to test the associations between IL-6 and these dimension scores. RESULTS: Based on data from 2731 participants, IL-6 was associated with diurnal mood variation, concentration difficulties, fatigue and sleep disturbances. The adjusted RRs for these symptoms at age 18 years for participants in top, compared with bottom, third of IL-6 at age 9 years were 1.75 (95% CI, 1.13-2.69) for diurnal mood variation, 1.50 (95% CI, 1.11-2.02) for concentration difficulties, 1.31 (95% CI, 1.12-1.54) for fatigue, and 1.24 (95% CI, 1.01-1.52) for sleep disturbances. At dimension level, IL-6 was associated with both somatic/neurovegetative (β = 0.059, SE = 0.024, P = 0.013) and psychological (β = 0.056, SE = 0.023, P = 0.016) scores. CONCLUSIONS: Inflammation is associated with specific symptoms of depression. Associations with so-called somatic/neurovegetative symptoms of depression such as fatigue, sleep disturbances and diurnal mood variation indicate that these symptoms could be useful treatment targets and markers of treatment response in clinical trials of anti-inflammatory treatment for depression.

Centre for Academic Mental Health Population Health Sciences Bristol Medical School University of Bristol Bristol UK; Institute of Psychological Medicine and Clinical Neurosciences Cardiff University Cardiff UK

Department of Psychiatry School of Clinical Medicine University of Cambridge Cambridge UK

Department of Psychiatry School of Clinical Medicine University of Cambridge Cambridge UK; Cambridgeshire and Peterborough NHS Foundation Trust Cambridge UK

Department of Psychiatry School of Clinical Medicine University of Cambridge Cambridge UK; Department of Kinanthropology Charles University Prague Czech Republic

Division of Psychiatry University College London London UK

Zobrazit více v PubMed

Aickin M., Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am. J. Public Health. 1996;86:726–728. PubMed PMC

Boyd A., Golding J., Macleod J., Lawlor D.A., Fraser A., Henderson J., Molloy L., Ness A., Ring S., Davey Smith G. Cohort Profile: the 'Children of the 90s'–the index offspring of the Avon Longitudinal Study of Parents and Children. Int. J. Epidemiol. 2013;42:111–127. PubMed PMC

Brydon L., Harrison N.A., Walker C., Steptoe A., Critchley H.D. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol. Psychiatry. 2008;63:1022–1029. PubMed PMC

Capuron L., Gumnick J.F., Musselman D.L., Lawson D.H., Reemsnyder A., Nemeroff C.B., Miller A.H. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643–652. PubMed

Capuron L., Fornwalt F.B., Knight B.T., Harvey P.D., Ninan P.T., Miller A.H. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J. Affect. Disord. 2009;119:181–185. PubMed PMC

Capuron L., Pagnoni G., Drake D.F., Woolwine B.J., Spivey J.R., Crowe R.J., Votaw J.R., Goodman M.M., Miller A.H. Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch. Gen. Psychiatry. 2012;69:1044–1053. PubMed PMC

Case S.M., Stewart J.C. Race/ethnicity moderates the relationship between depressive symptom severity and C-reactive protein: 2005–2010 NHANES data. Brain Behav. Immun. 2014;41:101–108. PubMed

Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9:46–56. PubMed PMC

Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry. 2010;67:446–457. PubMed

Duivis H.E., Vogelzangs N., Kupper N., de Jonge P., Penninx B.W. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA) Psychoneuroendocrinology. 2013;38:1573–1585. PubMed

Eisenberger N.I., Berkman E.T., Inagaki T.K., Rameson L.T., Mashal N.M., Irwin M.R. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatry. 2010;68:748–754. PubMed PMC

Felger J.C., Mun J., Kimmel H.L., Nye J.A., Drake D.F., Hernandez C.R., Freeman A.A., Rye D.B., Goodman M.M., Howell L.L., Miller A.H. Chronic interferon-alpha decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology. 2013;38:2179–2187. PubMed PMC

Felger J.C., Li Z., Haroon E., Woolwine B.J., Jung M.Y., Hu X., Miller A.H. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol. Psychiatry. 2016;21:1358–1365. PubMed PMC

Fraser A., Macdonald-Wallis C., Tilling K., Boyd A., Golding J., Davey Smith G., Henderson J., Macleod J., Molloy L., Ness A., Ring S., Nelson S.M., Lawlor D.A. Cohort Profile: the Avon Longitudinal Study of parents and children: ALSPAC mothers cohort. Int. J. Epidemiol. 2013;42(1):97–110. PubMed PMC

Gimeno D., Kivimaki M., Brunner E.J., Elovainio M., De Vogli R., Steptoe A., Kumari M., Lowe G.D., Rumley A., Marmot M.G., Ferrie J.E. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 2009;39:413–423. PubMed PMC

Goldsmith D.R., Rapaport M.H., Miller B.J. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry. 2016;21:1696–1709. PubMed PMC

Haapakoski R., Mathieu J., Ebmeier K.P., Alenius H., Kivimaki M. Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav. Immun. 2015;49:206–215. PubMed PMC

Haroon E., Fleischer C.C., Felger J.C., Chen X., Woolwine B.J., Patel T., Hu X.P., Miller A.H. Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Mol. Psychiatry. 2016;21:1351–1357. PubMed PMC

Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Critchley H.D. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry. 2009;66:407–414. PubMed PMC

Harrison N.A., Cercignani M., Voon V., Critchley H.D. Effects of inflammation on hippocampus and substantia nigra responses to novelty in healthy human participants. Neuropsychopharmacology. 2015;40:831–838. PubMed PMC

Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist. 1979;6:65–70.

Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009;71:171–186. PubMed

Janardhan V., Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J. Neurol. Sci. 2002;205:51–58. PubMed

Janeway C.A., Travers P., Walport M., Shlomchik M.J. Garland Science; New York: 2001. Immunobiology: The Immune System in Health and Disease.

Jokela M., Virtanen M., Batty G.D., Kivimaki M. Inflammation and specific symptoms of depression. JAMA Psychiatry. 2016;73:87–88. PubMed

Kapfhammer H.P. Somatic symptoms in depression. Dialogues Clin. Neurosci. 2006;8:227–239. PubMed PMC

Kappelmann N., Lewis G., Dantzer R., Jones P.B., Khandaker G.M. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol. Psychiatry. 2018;23:335–343. PubMed PMC

Khandaker, G.M., Zuber, V., Rees, J.M.B., Carvalho, L., Mason, A.M., Foley, C.N., Gkatzionis, A., Jones, P.B., Burgess, S., 2018b. Shared mechanism between depression and coronary heart disease: findings from Mendelian randomization analysis of a large UK population-based cohort (under review).

Khandaker G.M., Pearson R.M., Zammit S., Lewis G., Jones P.B. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71:1121–1128. PubMed PMC

Khandaker G.M., Stochl J., Zammit S., Goodyer I., Lewis G., Jones P.B. Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: a longitudinal cohort study. Psychol. Med. 2017:1–12. PubMed PMC

Khandaker G.M., Stochl J., Zammit S., Goodyer I.M., Lewis G., Jones P.B. Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: a longitudinal cohort study. Psychol. Med. 2017 in press. PubMed PMC

Khandaker G.M., Zammit S., Burgess S., Lewis G., Jones P.B. Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort. Brain Behav. Immun. 2018;69:264–272. PubMed PMC

Kohler-Forsberg O., Buttenschon H.N., Tansey K.E., Maier W., Hauser J., Dernovsek M.Z., Henigsberg N., Souery D., Farmer A., Rietschel M., McGuffin P., Aitchison K.J., Uher R., Mors O. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav. Immun. 2017;62:344–350. PubMed

Lewis G., Pelosi A.J., Araya R., Dunn G. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol. Med. 1992;22:465–486. PubMed

Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9:853–858. PubMed

Milaneschi Y., Lamers F., Peyrot W.J., Baune B.T., Breen G., Dehghan A., Forstner A.J., Grabe H.J., Homuth G., Kan C., Lewis C., Mullins N., Nauck M., Pistis G., Preisig M., Rivera M., Rietschel M., Streit F., Strohmaier J., Teumer A., Van der Auwera S., Wray N.R., Boomsma D.I., Penninx B., Group C.I.W., the Major Depressive Disorder Working Group of the Psychiatric Genomics, C. Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations. JAMA Psychiatry. 2017;74:1214–1225. PubMed PMC

Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry. 2009;65:732–741. PubMed PMC

Moieni M., Irwin M.R., Jevtic I., Olmstead R., Breen E.C., Eisenberger N.I. Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology. 2015;40:1709–1716. PubMed PMC

O'Brien S.M., Scully P., Fitzgerald P., Scott L.V., Dinan T.G. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J. Psychiatr. Res. 2007;41:326–331. PubMed

Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31. PubMed PMC

Raison C.L., Rutherford R.E., Woolwine B.J., Shuo C., Schettler P., Drake D.F., Haroon E., Miller A.H. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31–41. PubMed PMC

Statistics, O.o.N., 1980. Classification of occupations and coding index. Office of Population Censuses and Surveys. Her Majesty's Stationery Office, London, pp. x. http://www.ons.gov.uk/ons/guide-method/classifications/archived-standard-classifications/soc-and-sec-archive/index.html.

WHO . World Health Organization; 1992. The ICD-10 Classification of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines.

Wium-Andersen M.K., Orsted D.D., Nielsen S.F., Nordestgaard B.G. Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry. 2013;70:176–184. PubMed

Zalli A., Jovanova O., Hoogendijk W.J., Tiemeier H., Carvalho L.A. Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology. 2016;233:1669–1678. PubMed PMC

Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort